2 w. ago NovoCure (NVCR): Assessing Valuation After Japan Approves Optune Lua for Advanced Lung Cancer Therapy

NovoCure (NVCR): Assessing Valuation After Japan Approves Optune Lua for Advanced Lung Cancer Therapy  simplywall.st

Other

2 w. ago Verrica Pharmaceuticals Announces $10 Million Milestone Payment Following YCANTH® Approval in Japan for Molluscum Treatment

Verrica Pharmaceuticals Announces $10 Million Milestone Payment Following YCANTH® Approval in Japan for Molluscum Treatment  Quiver Quantitative

Other

3 w. ago Novavax (NVAX): Assessing Valuation After Japan Vaccine Approval and Takeda Milestone Payment

Novavax (NVAX): Assessing Valuation After Japan Vaccine Approval and Takeda Milestone Payment  simplywall.st

Other

3 w. ago Assessing the Valuation of Japan Elevator Service Holdings (TSE:6544) After a Year of Strong Stock Gains

Assessing the Valuation of Japan Elevator Service Holdings (TSE:6544) After a Year of Strong Stock Gains  Yahoo Finance

Other

3 w. ago Assessing ARIAKE JAPAN (TSE:2815) Valuation as Market Interest Builds

Assessing ARIAKE JAPAN (TSE:2815) Valuation as Market Interest Builds  simplywall.st

Other

3 w. ago Assessing Japan Metropolitan Fund Investment (TSE:8953) Valuation After Recent Steady Share Price Gains

Assessing Japan Metropolitan Fund Investment (TSE:8953) Valuation After Recent Steady Share Price Gains  simplywall.st

Other

3 w. ago Assessing Japan Metropolitan Fund Investment (TSE:8953) Valuation Following Recent Uptrend in Market Activity

Assessing Japan Metropolitan Fund Investment (TSE:8953) Valuation Following Recent Uptrend in Market Activity  sg.finance.yahoo.com

Other

3 w. ago Why Novavax (NVAX) Is Up 7.6% After Japan Approves New Omicron Vaccine and Triggers Royalties

Why Novavax (NVAX) Is Up 7.6% After Japan Approves New Omicron Vaccine and Triggers Royalties  simplywall.st

Other